Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Change in Acquisitions & Divestments (2016 - 2026)

Scynexis' (SCYX) quarterly Change in Acquisitions & Divestments came in at $11.5 million in Q2 2026, up 1.61% on a YoY basis from $11.3 million in Q2 2025, and up 316.55% quarter-over-quarter from $2.8 million in Q1 2026.

Analysis

Scynexis (SCYX) Change in Acquisitions & Divestments (2016 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Change in Acquisitions & Divestments for 9 consecutive years, with $11.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Acquisitions & Divestments rose 1.61% year-over-year to $11.5 million; the trailing twelve-month figure through Jun 2026 stood at $33.7 million (down 30.85% YoY), and the FY2025 full-year result was $43.2 million, up 1.51% from the prior year.
  • Change in Acquisitions & Divestments climbed to $11.5 million in Q2 2026 per SCYX's latest filing, from $2.8 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $20.6 million in Q2 2023 and bottomed at $2.8 million in Q1 2026.
  • Historically, Change in Acquisitions & Divestments has averaged $11.6 million across 4 years, with a median of $11.3 million in 2025.
  • The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments jumped 56.2% in 2025, then slumped 77.89% in 2026.
  • Over 4 years, Change in Acquisitions & Divestments stood at $10.1 million in 2023, then plunged by 42.16% to $5.8 million in 2024, then advanced by 21.74% to $7.1 million in 2025, then surged by 61.82% to $11.5 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $11.5 million, $2.8 million, and $7.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Scynexis 58.41 Mn -56.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.46 Mn
Mar 31, 2026 2.75 Mn
Dec 31, 2025 7.08 Mn
Sep 30, 2025 12.42 Mn
Jun 30, 2025 11.27 Mn
Mar 31, 2025 12.44 Mn
Dec 31, 2024 5.82 Mn
Sep 30, 2024 19.21 Mn
Jun 30, 2024 9.58 Mn
Mar 31, 2024 7.96 Mn
Dec 31, 2023 10.05 Mn
Sep 30, 2023 19.99 Mn
Jun 30, 2023 20.56 Mn
Sep 30, 2020 3.57 Mn
Jun 30, 2020 10.67 Mn
Mar 31, 2020 6.48 Mn
Dec 31, 2019 11.04 Mn
Sep 30, 2019 11.50 Mn
Jun 30, 2019 18.56 Mn
Mar 31, 2019 24.64 Mn